[Comparative anti-arrhythmia effectiveness of activators of body stress-limiting systems in patients with arrhythmia].
The antiarrhythmic effects produced by activators of the body's stress-limiting systems were comparatively evaluated in patients with cardiac arrhythmias of ischemic and non-ischemic etiology. Acediprol, gidazepam, and befol were found to be beneficial in ventricular premature contraction when psychoemotional stress was simulated, as evidenced by 24-hour monitoring. The most pronounced protective therapeutical effect of the drugs was observed in patients with arrhythmias of extracoronary origin and in individuals with a marked arrhythmogenic effect of stress. Gidazepam was shown to suppress the provocative arrhythmogenic effect of the stress test.
Meerson
F Z
FZ
Skibitskiĭ
V V
VV
D000328:Adult; D000368:Aged; D000787:Angina Pectoris / Q000503:physiopathology; D014151:Anti-Anxiety Agents; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D001549:Benzamides / Q000627:therapeutic use; D001569:Benzodiazepines; D001570:Benzodiazepinones / Q000627:therapeutic use; D003327:Coronary Disease / Q000503:physiopathology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009025:Morpholines / Q000627:therapeutic use; D009449:Neurocirculatory Asthenia / Q000503:physiopathology; D011963:Receptors, GABA-A / Q000187:drug effects; D013312:Stress, Physiological / Q000503:physiopathology; D014635:Valproic Acid / Q000627:therapeutic use
D014151:Anti-Anxiety Agents; D000889:Anti-Arrhythmia Agents; D001549:Benzamides; D001570:Benzodiazepinones; D009025:Morpholines; D011963:Receptors, GABA-A; D001569:Benzodiazepines; D014635:Valproic Acid; C059049:befol; C077010:gidazepam
Sravnitel'naia antiaritmicheskaia éffektivnost' aktivatorov stress-limitiruiushchikh sistem organizma u bol'nykh s narusheniiami ritma serdtsa.